CAPTRUST Financial Advisors’s Corcept Therapeutics CORT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $597K | Sell |
8,131
-1,001
| -11% | -$73.5K | ﹤0.01% | 1624 |
|
|
2025
Q1 | $1.04M | Sell |
9,132
-104,856
| -92% | -$12M | ﹤0.01% | 1246 |
|
|
2024
Q4 | $5.74M | Buy |
113,988
+10,248
| +10% | +$516K | 0.02% | 501 |
|
|
2024
Q3 | $4.8M | Sell |
103,740
-19,255
| -16% | -$891K | 0.01% | 542 |
|
|
2024
Q2 | $4M | Sell |
122,995
-6,676
| -5% | -$217K | 0.01% | 562 |
|
|
2024
Q1 | $3.27M | Sell |
129,671
-12,401
| -9% | -$312K | 0.01% | 624 |
|
|
2023
Q4 | $4.61M | Sell |
142,072
-908
| -0.6% | -$29.5K | 0.02% | 585 |
|
|
2023
Q3 | $3.9M | Sell |
142,980
-85,187
| -37% | -$2.32M | 0.01% | 606 |
|
|
2023
Q2 | $5.08M | Buy |
228,167
+621
| +0.3% | +$13.8K | 0.02% | 502 |
|
|
2023
Q1 | $4.93M | Buy |
227,546
+208,844
| +1,117% | +$4.52M | 0.02% | 464 |
|
|
2022
Q4 | $380K | Buy |
18,702
+147
| +0.8% | +$2.99K | ﹤0.01% | 1488 |
|
|
2022
Q3 | $476K | Buy |
18,555
+10,923
| +143% | +$280K | ﹤0.01% | 1275 |
|
|
2022
Q2 | $181K | Buy |
7,632
+827
| +12% | +$19.6K | ﹤0.01% | 1758 |
|
|
2022
Q1 | $153K | Buy |
6,805
+3,181
| +88% | +$71.5K | ﹤0.01% | 1924 |
|
|
2021
Q4 | $72K | Buy |
3,624
+256
| +8% | +$5.09K | ﹤0.01% | 2389 |
|
|
2021
Q3 | $66K | Buy |
3,368
+37
| +1% | +$725 | ﹤0.01% | 2390 |
|
|
2021
Q2 | $73K | Sell |
3,331
-644
| -16% | -$14.1K | ﹤0.01% | 2249 |
|
|
2021
Q1 | $95K | Buy |
3,975
+3,755
| +1,707% | +$89.7K | ﹤0.01% | 1995 |
|
|
2020
Q4 | $6K | Buy |
220
+100
| +83% | +$2.73K | ﹤0.01% | 2762 |
|
|
2020
Q3 | $2K | Buy |
+120
| New | +$2K | ﹤0.01% | 2745 |
|